Catalyst Wire Dossier Catalyst Wire Dossier

Yescarta (axicabtagene ciloleucel)

axicabtagene ciloleucel · Gilead Sciences
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Yescarta (axicabtagene ciloleucel), covering 2026-01-14 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy. [Phase 2]

See pricing